Alsaadi, Taoufik http://orcid.org/0000-0002-7513-5706
Noori, Suzan
Varakian, Razmig
Youssef, Saly
Almadani, AbuBaker
Article History
Received: 28 January 2022
Accepted: 9 May 2022
First Online: 16 June 2022
Declarations
:
: All relevant ethical, health authority, data privacy and site-specific approvals were obtained prior to the start of the study. The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from patients before data collection. Depending on each site’s local Institutional Review Board (IRB) regulations, a waiver of informed consent from the corresponding ethics committee was obtained. All authors were given access to the study data. The study protocol and ICF consent waiver has been reviewed and approval granted by the below mentioned ethics committees and HA: ACPN Institutional Review Board for ACPN site. Ministry of Health and Prevention for University of Sharjah site. University of Sharjah Ethics and Research Committee for University of Sharjah site. Dubai Scientific Research Ethics Committee for Rashid hospital site.
: Not applicable.
: TA, SN and ABA have nothing to disclose. RV and SY are employees of Novartis Middle East FZE, Representative Office, Dubai, United Arab Emirates.